"We basically scrapped using [stem] cells. The placement of this biopolymer gave us an immediate response. It took us literally hours to see a change in the heart's functionality."

—Ray Cohen CEO of Symphony Medical discussing the company's decision to use a biopolymer instead of stem cells in developing its congestive heart failure therapy, "Symphony goes with biopolymer over stem cells for CHF treatment."

No Comments